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Abstract 
Despite the advances in perinatal and neona-
tal care and use of newer potent antibiotics, the
incidence of neonatal sepsis  remains high and
the outcome is still severe. For years, investiga-
tors have sought a test or panel of tests able to
identify septic neonates accurately and rapidly
in order to obtain an early diagnosis and devel-
op a specific effective treatment for a successful
outcome. In addition to the standard procedures
(blood, CSF, and urine cultures), such panels
have included a combination of haematological
investigations (total, differential and immature
cell counts), and levels of acute-phase reactants
(principally  CRP  and  procalcitonin),  and
cytokines (such as IL-6 or neutrophil CD64).
Furthermore,  the  science  of  proteomics  and
genomics has been applied to the search for bio-
markers,  production  of  protein  profiles  and
genetic polymorphisms  that can rapidly help
the prediction, early diagnosis, and treatment of
human diseases, but, for now, data are as yet
insufficient to confirm their validity. 
Introduction
The high incidence and severe outcome of
neonatal sepsis, despite the advances in perina-
tal and neonatal care and use of newer potent
antibiotics, is mainly related to the combination
of the neonatal reduced immune defence and
the complex interactions between the infecting
microorganism and the host response.1-3 These
factors  are  only  partially  mitigated  by  the
transplacental passage of IgG antibodies from
mother  to  fetus  during  intrauterine  life.  An
additional  naturally  occurring  compensatory
mechanism is represented by human milk, that
after  birth  maintains  the  mother-newborn
immunological link by providing a host of pro-
tective components.4
Sepsis is a pathogen initiated but a cytokine-
mediated condition in which immune, inflam-
matory,  and  coagulation  homeostasis  is  dis-
turbed.5 The evolution of disease and clinical
symptoms are dependent upon a complex and
delicate balance between the pro-inflammatory
and anti-inflammatory factors. The inflammato-
ry cytokines (TNF-α, IL-1β, IL-6, IL-8, IL-15, IL-
18, MIF) and growth factors (IL-3, CSFs), and
their  secondary  mediators,  including  nitric
oxide,  thromboxanes,  leukotrienes,  platelet-
activating  factor,  prostaglandins,  and  comple-
ment, cause activation of the coagulation cas-
cade, the complement cascade, and the produc-
tion of prostaglandins, leukotrienes, proteases
and oxidants. Most of the short (from systemic
inflammatory response syndrome - SIRS, and
disseminated intravascular coagulation - DIC,
to septic shock, and multiple organ dysfunction
syndrome - MODS) and long term complication
(respiratory,  growth  and  neurological  seque-
lae6) of neonatal sepsis are strictly associated to
the effects of these mediators,7-9 not counter-
balanced  by  an  adequate  synthesis  of  anti
inflammatory  cytokines,  as  TNFsr,  IL-1ra,  IL-
1rII, IL-10, TGF-β2. 
Diagnosis of infection
The isolation of microorganisms from  blood,
cerebrospinal fluid (CSF) or urine remains the
gold standard for definitive diagnosis, however,
confirmation or exclusion of positive cultures
requires days, and more importantly, the sensi-
tivity of the culture methods is frequently low,
due to the concomitant antibiotic therapy, or to
the combination of small blood sample volume
and low colony counts. When a 0.5 mL blood
sample is obtained for culture (a likely occur-
rence  in  NICUs),  the  probability  to  isolate
organisms is 0.39 with one CFU/mL, 0.67 with
two CFU/mL, 0.87 with four. A count of at least 4
CFU/mL and one ml blood volume are necessary
to reach a probability of 0.98.10
In addition, in neonates the clinical signs of
sepsis are poor, late and non specific, particular-
ly in preterm infants, in whom the onset of sep-
sis may be acute and clinical course can quickly
deteriorate. 
Therefore, early diagnosis of a life-threaten-
ing disease like neonatal sepsis, is the manda-
tory prerequisite for a timely treatment.11
For years, investigators have sought a test or
panel of tests able to identify septic neonates
accurately  and  rapidly  while  awaiting  culture
results, in order to obtain an early diagnosis and
develop a specific effective treatment for a suc-
cessful outcome.
Diagnostic  test  characteristics  significantly
change depending on sensitivity, specificity and
predictive value. In relation to neonatal infec-
tion, these terms can be defined as follows:12
- Sensitivity (positive test/positive diagnosis):
if infection is present, how often is the test
result abnormal?
- Specificity  (negative  test/negative  diagno-
sis): if infection is absent, how often is the
test result normal?
- Positive  predictive  value  (positive  diagno-
sis/positive test): if the test result is abnor-
mal, how often is infection present?
- Negative predictive value (negative diagno-
sis/negative test): if the test result is normal,
how often is infection absent?
- Likelihood ratio, positive test result: if the
result is abnormal, how much does that result
raise the pretest probability of disease?
- Likelihood ratio, negative test result: if the
result is normal, how much does that result
lower the pretest probability of disease?
Large (>5-10) or small (<0.1-0.2) likelihood
ratios significantly raise or minimize the prob-
ability of the disease being present.
The true positive rate (sensitivity) may be
graphically  plotted  against  the  false  positive
rate (1 - specificity) for the different possible
cut-off points of a diagnostic test, in order to
obtain  a  Receiver  Operating  Characteristic
(ROC) curve. The area under an ROC curve is a
measure of test accuracy, the closer the curve
follows the left-hand border and then the top
border of the ROC space, the more accurate the
test.13
Diagnostic tests with maximal (100%) sensi-
tivity and negative predictive value are desir-
able for diagnosis of neonatal sepsis. In other
words, if infection is present, the result would
always  be  abnormal;  if  the  result  is  normal,
infection would always be absent. The reduced
specificity and positive predictive value are usu-
ally  acceptable  because  over  treatment  with
antibiotics on the basis of a false-positive result
is likely to be of limited harm compared with
withholding therapy on the basis of a false-neg-
ative result. Although this approach seems rea-
sonable  given  the  dire  outcome  of  a  missed
diagnosis, improvement in diagnostic accuracy
should  diminish  the  exposure  of  healthy
neonates to the risks of unwarranted antibiotic
treatment, decrease antibiotic resistances, and
reduce the length and cost of hospital stays.12
Nonspecific  laboratory  investigations  for  the
diagnosis  of  invasive  bacterial  infections
remain the most important diagnostic aid for
the management of septic neonates14 (Table 1). 
White blood cell counts and ratios
Total leukocyte count (>20000 or <5000), dif-
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ferential leukocyte count and morphology, total
neutrophil  count,  total  nonsegmented  neu-
trophil count, neutrophil ratios, platelet count
are  the  indices  most  commonly  used.  These
haematological counts and ratios showed a lim-
ited accuracy with wide range of sensitivity (17-
90%) and specificity (31-100%), due to the rela-
tively long period necessary to become positive
and  the  significant  influence  of  non-specific
factors. 
However,  the  band  neutrophil:total  neu-
trophil (IT) ratio of >0.2 may reach a sensitivi-
ty  of  90%  and  negative  predictive  value  of
98%.15,16 Indeed, the IT ratio is less influenced
by  non  infectious  factors,  as  the  method  of
delivery.17
C-Reactive Protein
C-Reactive Protein (CRP) is a globulin that
forms a precipitate when combined with the C-
polysaccharide of Streptococcus pneumoniae. It
is  the  most  extensively  acute  phase  reactant
studied so far. 
The sensitivity is low for early diagnosis of
sepsis, due to the relatively long time, 6-8 hours
following the stimulus, required for synthesis;
the peak is observed at 24 hours, and the half
life is 19 hours.
The qualitative assay of CRP does not offer
significant advantages on the leukocyte index-
es. On the other hand, quantitative CRP values,
particularly when repeated, are highly specific
and  have  good  sensitivity.  In  addition,  serial
measurements can be helpful in monitoring the
response to treatment. Two serial CRP values
<1  mg/dL,  excluding  the  investigation  soon
after  birth,  carry  a  99%  negative  predictive
value. In spite of the reduced early sensitivity,
CRP still remains the preferred index in most
NICUs.
Erythrocyte sedimentation rate
Microerythrocyte sedimentation rate (micro-
ESR) by the use of a microhematocrit tube has
been developed over 50 years ago. Normal val-
ues changes significantly during the first two
weeks of life, and can be calculated by adding 2
or 3 to the age of the infant in days. Micro-ESR
is quite specific; however, sensitivity is low due
to the rise delay and to the long time required
for  normalization  after  clinical  recovery.  For
these reasons it is considered of little value in
either  diagnosing  or  monitoring  infection  in
the neonate.12
Procalcitonin
Procalcitonin, a propeptide of calcitonin, is
released into the blood 3 to 6 hours after endo-
toxin injection and increases up to 24 hours; the
increase does not correlate with calcitonin lev-
els and occurs even in subjects who have had
thyroidectomy.
Very  high  serum  procalcitonin  levels  are
present in neonates with proven or clinically
diagnosed bacterial infection; early decrease of
these  concentrations  reflects  appropriate
antibiotic therapy.18
Daily  variations  of  procalcitonin  levels  in
noninfected neonates have been reported, with
a peak on day 1-2 of life, followed by a regular
decrease to normal levels.19,20
Compared  with  CRP,  procalcitonin  has  the
advantage that it increases more rapidly; how-
ever, the significant rapid variations of basal
levels after birth, and the need for several differ-
ent cut-off values with changing neonatal age,
have  limited  the  diffusion  of  this  marker  in
comparison to the CRP.21 Nevertheless, a recent
meta-analysis  suggested  that  procalcitonin
showed better accuracy than the CRP test for
the diagnosis of late-onset sepsis.22
In our opinion, procalcitonin should be used
as  an  adjunct,  rather  than  a  replacement,  to
CRP to improve the diagnostic accuracy.
Increases of the above indices have been also
associated with several non-infectious perinatal
factors causing tissue injury or inflammation,
such as maternal hypertension, mode of deliv-
ery,  asphyxia,  respiratory  distress  syndrome,
intracerebral  hemorrhage,  meconium  aspira-
tion  syndrome,  prolonged  crying,  haemolytic
disease, surgery,12 or post-natal age.23
Therefore,  haematological indices for diag-
nosis of neonatal sepsis are of limited value in
the early diagnosis of infection in this popula-
tion.24Clinicians faced with a neonate with sus-
pected sepsis cannot rely on either C-reactive
protein  or  leukocyte  indices  or  procalcitonin
alone to make a decision, given that the results
vary significantly depending on the methods of
measurement used and the target population. 
Cytokines (and receptors) in the diagnosis of
infection in neonates
An important limit of haematological indices
for early diagnosis of sepsis is the time required
for the test to become positive. It takes several
hours  for  leukocyte  indices  and  acute-phase
reactants to change significantly after the onset
of reaction.
The cascade of events initiated by the bacter-
ial infection usually begins with the activation
of  macrophages  and  release  of  inflammatory
cytokines (TNF-α, IL-1β, IL-6) and growth fac-
tors (IL-3, CSFs). These trigger the inflammato-
ry reaction, with acute phase reactants synthe-
sis by the liver and activation of neutrophils.
The  increase  of  cytokines  levels  is  therefore
observed much earlier than that of haematolog-
ical indices (Figure 1).
Several cytokines and receptors have been
evaluated for the early diagnosis of infection in
neonates (Table 1).25-33
lnterleukin-6 (IL-6) is a pleiotropic cytokine
involved in many aspects of the immune sys-
tem. It is synthesized by a number of cells, such
as monocytes, endothelial cells, and fibroblasts,
after TNF and IL-1 stimulation. IL-6 is the major
inducer of hepatic acute-phase protein synthe-
sis,  including  CRP  and  fibrinogen.  In  most
cases of neonatal sepsis, IL-6 increases rapidly,
several hours before the increase in the concen-
tration of CRP, and decreases within 24 hours to
undetectable levels. The short half-life of IL-6 is
caused by binding to plasma proteins such as
α2-macroglobulin, early clearance in the liver,
and inhibition by other cytokines.
When used as a very early marker of infec-
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tion, IL-6 has good sensitivity and good speci-
ficity.
A study showed that IL-6 and interleukin-1
receptor antagonist (IL-1ra) increased signifi-
cantly two days before clinical diagnosis of sep-
sis. The diagnostic sensitivities of IL-1ra, IL-6,
and CRP concentrations on day 0 of diagnosis
were 93%, 86%, and 43%, respectively; corre-
sponding  values  one  day  before  diagnosis  of
infection were 64%, 57%, and 18%. The speci-
ficities of IL-1ra, IL-6, and CRP concentrations
were 92%, 83%, and 93%.26
In contrast to CRP, IL-6 is a very early marker,
but levels can become normal even if infection
continues. This leads to an increasing propor-
tion of false-negative findings when sampling is
performed later in the course. The simultane-
ous determination of CRP can obviate this prob-
lem,  because  the  rise  in  plasma  CRP  levels
occurs 12 to 48 hours after the onset of infec-
tion, at a time when IL-6 levels probably would
have fallen. When these two markers are com-
bined, the sensitivity is high for infected infants
at any postnatal age. The specificity of IL-6 is
reduced in infants with perinatal asphyxia.
Screening panels
None of the adjunctive tests considered earli-
er  is  sufficiently  sensitive  and  specific  to
exclude or confirm the diagnosis of neonatal
sepsis.  Clinicians  have  considered  screening
panels or a sepsis screen that combine data from
several individual analyses. In addition to the
standard procedures (blood, CSF, and urine cul-
tures, chest film), such panels have included a
combination of total and differential cell counts,
total immature neutrophil counts, immature to
total neutrophil ratio, platelet counts, and levels
of acute-phase reactants and cytokines.
At present, the best combination of markers
for diagnosing sepsis consists of performing IL-
6 and IL-1ra one-two days before the onset of
symptoms, IL-6 (or IL1-ra, IL-8, CD11b, CD64, G-
CSF, TNF-α), CRP, procalcitonin, and haemato-
logical indices on day 0, CRP, haematological
indices, and procalcitonin on the following days
to monitor the response to therapy.
Overall,  the  results  of  these  studies  have
shown little increase in positive predictive value
compared with most of the individual screening
tests,  although  negative  predictive  value  is
remarkably  good,  approaching  100%  in  some
studies. Because of the high negative predictive
value, screening panels may produce a signifi-
cant  decrease  in  the  use  of  antimicrobial
agents. With their use, fewer neonates would
receive  antimicrobial  agents,  and  antibiotic
treatment could be more confidently discontin-
ued earlier.12,14
It  should  be  emphasized,  however,  that
screening tests are intended only to augment
clinical evaluation. When the evidence obtained
by  history  or  physical  examination  conflicts
with a negative screen, antimicrobial therapy
should be started. Thus, clinical signs of sepsis
remain the most important criteria for use of
antimicrobial agents.
Proteomics and genomics
Modern applications of molecular pathology
embrace  various  disciplines:  genomics
(sequence DNA), transcriptomics (mRNA iden-
tification), proteomics (protein identification)
and pharmacogenomics (genes that define the
behavior of drugs). 
Proteomics is the study of expressed proteins
in a tissue, cell, or organism at a given moment.
It is more clinically significant and easier to
translate into diagnostic tools and therapeutical
strategies than genomics, which studies DNA.
In fact, proteomics examine directly functional
molecules and not the source code. Evidence to
support this statement is that protein quantity
and  activity  do  not  show  a  relationship  with
mRNA amount.
The science of proteomics has been applied
to the search for biomarkers and production of
protein profiles that can rapidly help the predic-
tion, early diagnosis, and treatment of human
diseases.27
Several informations can be obtained from
proteomics study, although only part of these
are  biologically  significant.  To  analyze  pro-
teomics data from SELDI-TOF(enhanced laser
desorption/ionization  time  of  flight)  outputs,
Buhimschi et al. developed a strategy to extract
significant proteomic biomarkers characteristic
for  intra-amniotic  inflammation,  based  on
sequentially  applied  filter  preferences.  This
strategy was called mass restricted (MR) scor-
ing. The MR score indicate the number of iden-
tifiable markers among the following factors of
innate immunity: neutrophil defensin-2, neu-
trophil defensin-1, S100A12 (calgranulin C) and
S100A8 (calgranulin A).34
An MR score of 3-4 indicated the presence of
inflammation, while a score of 0-2 excluded it.
The same authors prospectively validated the
clinical  utility  of  the  MR  score  in  predicting
preterm births and neonatal sepsis in a cohort
of 169 consecutive women with single pregnan-
cies. An MR score of 3-4 had the highest accura-
cy (92.6%) in diagnosing intra-amniotic inflam-
mation, and was significantly better than white
blood cell (WBC) count or IL-6. Therefore, high
MR scores are associated with preterm delivery,
histological  chorioamnionitis,  and  early-onset
neonatal sepsis (EONS).
Detection of monomeric S100A8 (calgranulin
A) in the amniotic fluid was closely associated
with EONS. The gestational age and the pres-
ence of S100A12 and S100A8 in amniotic fluid
tightly correlated with neonatal neuro-develop-
mental impairment.
In conclusion, the amniotic fluid proteome
closely reflects the fetal inflammatory response
to intra-amniotic infection and SELDI-TOF tech-
nology  carries  the  attributes  to  allow  for  a
direct, rapid and reliable identification of pro-
teomic  biomarkers  of  intrauterine  inflamma-
tion.
There are also molecular-based approaches
for diagnosis of neonatal infection: 
i) whole blood directly tested by target ampli-
fication; ii) whole blood pre-enrichment before
target  amplification;  iii)  fluids  from  positive
blood culture bottles tested by polymerase chain
reaction  (PCR);  iv)  Nucleic  Acid  Sequence-
Based Amplification (NASBA); v) Nucleic Acid
Amplification Tests (NAAT); vi) PCR in conjunc-
tion  with  sequencing  or  microarray  analysis;
vii)  non  amplification-based  fluorescence  in
situ hybridization (FISH).
The  sensitivity  and  specificity  of  real-time
PCR assay was 96.2% and 100% respectively,35
with a limit of recognition for E.Coli and group
B Streptococcus, while in another study that tar-
geted several larger 16S rDNA, was 66.7% and
87.5%.36
Makhoul et al. showed that sensitivity, speci-
ficity, positive predictive value and negative pre-
dictive  value  of  Staphylococcus-specific  PCR,
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Table 1. Laboratory investigations for diagnosis of neonatal sepsis 
Specific laboratory tests
Blood, cerebrospinal fluid and urine culture
Direct visualisation of bacteria (Gram stain …..)
Detection of bacterial antigens
Polymerase chain reaction (amplification of bacterial DNA, i.e. 16S rDNA)
Haematological investigations
White blood cell counts, total and differential, platelet count
CRP, procalcitonin, ESR, serum amyloid, other acute phase reactants: haptoglobin, lactoferrin, 
neopterin, inter-inhibitor proteins (I￿Ips), lipopolysaccharide-binding protein (LBP), C5a, C5L2,
immunoglobulins
Cytokines and receptors 
IL-1￿, IL-6, IL-8, IL-10
IL-1ra, IL-2rs
IP-10, RANTES, TNF-α, IFN-g
G-CSF, CSF1, SCF
MIP1-a
sCD14, sICAM-1, CD11b, CD64, CD69, CD25, CD45RO, CD19, CD33, CD66b
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used for detection of staphylococcal bacteremia,
was 57.1%, 94.7%, 53.3% and 95.4%, respective-
ly.37
A  technique  based  on  PCR  to  amplify  the
gene cfb directly from swabs to accurately iden-
tify the colonization by group B streptococcus,
with  results  within  1-2  hours,  was  recently
approved for use in both prepartum and intra-
partum by the Food and Drug Administration
(FDA),  while  NAAT  for  Perinatal  Group  B
Streptococcus identification has been consid-
ered in the most recent Guidelines from CDC.38
Despite the cfb-PCR has been approved by the
FDA, Atkins39 showed, by comparing the PCR
and double (direct inoculation on selective agar
and broth) culture methods in a study of 233
samples, that PCR had sensitivity, specificity,
positive and negative predictive value of 86.8%,
95.2%,  88.1%  and  94.6%,  respectively,  with  a
false negative rate of 13.2%. 
Using whole blood directly in a target ampli-
fication-based assay for detecting bacteria has
the advantage of rapid diagnosis, but the chal-
lenges of suboptimal sensitivity and specificity.
Several strategies are under investigations to
improve this problem, as an increase of blood
volume (but it is not always possible, particular-
ly in small infants), improvement of extraction
procedures to obtain greater recovery of bacter-
ial nucleic acid over human genomic DNA, or
whole blood pre-enrichment. 
Bacterial  detection  platforms  such  as  DNA
microarray, FISH, and mass spectrometry do not
require  target  amplification.  Several  studies
reported that the sensitivity and the specificity
of this molecular-based approaches was from
98-100% and from 99-100%, respectively.
The  major  benefit  of  a  molecular  test  is
speed; however, so far, none of the rapid test has
been shown to have a sensitivity and specificity
sufficient  to  replace  standard  blood  culture
techniques, that carries the additional impor-
tant  advantage  of  the  ability  of  testing
pathogens antibiotics susceptibility.
Genetic polymorphisms
The possibility of understanding the genetic
contribution to response to microbial pathogens
remains one of the most stimulating prospects
of the unravelling of the human genome. The
identification  of  strong  associations  between
certain genetic polymorphisms and susceptibil-
ity to severe sepsis supports further research
using appropriate association studies.40
Recent evidence that the genetic background
of  the  host  affects  the  systemic  response  to
infection has stimulated considerable interest
in  the  evaluation  of  genetic  susceptibility  to
sepsis, concerning in particular factors of the
initial immune response of the innate immuni-
ty, as Toll-like receptors (TLRs), mannose-bind-
ing lectin (MBL), nucleotide-binding oligomer-
ization domain (NODs) and cytokines.41-43
Genes involved in the regulation of immune
function, particularly the systemic inflammato-
ry response, have been evaluated in an attempt
to identify markers of infection in neonates.44
A research performed on two polymorphisms
of TNF did not provide evidence that these can
influence the incidence of early-onset sepsis in
premature infants.45
Other studies about IL-6 failed to identify a
strong  genetic  correlation.46,47 A  recent  meta-
analysis assessed the evidence for the associa-
tion of the IL-6 (-174C) polymorphism (guani-
dine  to  cytosine  transition  at  position  -174
nucleotides  relative  to  the  transcription  start
site in the interleukin-6 gene) with the risk of
sepsis in Very Light Birth Weight (VLBW)  new-
born infants. The results of six cohort studies
including a total of 1323 VLBW infants found no
significant association between carriage of the
IL-6 (-174C) polymorphism and sepsis: pooled
relative risk 0.90 (95% CI 0.62 to 1.31). These
data did not support screening infants for this
allele in order to guide selective antimicrobial
prophylaxis.48
As  the  inflammatory  cytokine  cascade  is
implicated in the pathogenesis of necrotising
enterocolitis (NEC), the associations between
the  common  genetic  variants  in  candidate
inflammatory  cytokine  genes  and  NEC  in
preterm infants was examined in a meta-analy-
sis.  Ten  single-nucleotide  polymorphisms  in
cytokines previously associated with infectious
or inflammatory diseases were genotyped: TNF
(2308A), TNF (2238A), IL1 (231G), IL1 (2511T),
IL4R (+1902G), IL6 (2174C), IL8 (2251A), IL10
(21082G),  IL18  (2137C),  IL18  (2607A).  The
results suggested that available data were not
consistent with more than modest associations
between these candidate cytokine variant alle-
les and NEC in preterm infants.49
Del Vecchio et al compared the prevalence of
TNF-α and  IL-10  polymorphisms  in  preterm
neonates with late-onset sepsis with a nonin-
fected reference group. In the septic neonates,
308G-TNF-α and  1082-IL-10  polymorphisms
resulted,  in  homozygous  and  heterozygous
forms,  more  frequent  with  statistical  signifi-
cance. The authors, however, concluded that the
analysis of a larger group of subjects was need-
ed to confirm these data.50
Recently, a significant association of  IL-6-
174CC  and  IL-10-1082GG  genetic  polymor-
phisms in homozygosis with increased risk of
mortality was reported. Moreover, the studied
genotypes were significantly higher in neonates
who required inotropic support and those who
developed  disseminated  intravascular  coagu-
lopathy.51
Conclusions
On the whole, these preliminary studies tend
to confirm that genetic variations and single
nucleotide polymorphisms of factors involved in
the immune defence against infection are sig-
nificantly involved in the pathogenesis of sep-
sis, and may influence the outcome. Data, how-
ever, are as yet insufficient to consider these
factor useful for the evaluation of the risk to
develop sepsis, or to include any of these mark-
ers in the screening panels currently used for
the early diagnosis or to guide the treatment of
infection in the neonate.52
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